Document is current

Any future updates will be listed below

Correction: Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison

Crossref DOI link: https://doi.org/10.1007/s41030-025-00332-z

Published Online: 2025-11-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark